Nu Skin Enterprises Q4 2023 Adj EPS $0.37 Beats $0.28 Estimate, Sales $488.64M Beat $476.39M Estimate
Portfolio Pulse from Benzinga Newsdesk
Nu Skin Enterprises (NUS) reported Q4 2023 adjusted EPS of $0.37, surpassing the $0.28 estimate, with sales of $488.64M also beating the $476.39M estimate. However, this represents a 6.45% decrease in sales compared to the same period last year.
February 14, 2024 | 9:29 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Nu Skin Enterprises reported a strong Q4 2023 with adjusted EPS and sales beating estimates, despite a year-over-year sales decrease.
Beating both EPS and sales estimates typically generates positive investor sentiment, potentially leading to a short-term stock price increase. However, the year-over-year decrease in sales might temper some of the enthusiasm, suggesting a cautious optimism.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100